MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Oncolytics Biotech, Inc. Common Shares

ONCY

#4063
Oncolytics Biotech Inc. - Common Stock
0.4 9 USD
+0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
0.45
0.50
Year Range
0.44
1.32
Daily Change
+4.26%
Monthly Change
-40.96%
6 month change
-51.96%
Year Change
-59.17%
Previous Close
0.4 7
Open
0.4 9
Low
0.4 5
High
0.5 0
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. Biotechnology
  5. ONCY
Open full chart

Financials

Overview Statement Statistics Documents

2001

Annual report, Q4 FY2001

2002.06.14
ONCOLYTICS BIOTECH INC annual report, Q4 FY2001
20-F
  • 1
  • ...
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105

News

Benzinga
ONCY
2 days ago, 20:08

Oncolytics Biotech Expands Pelareorep Patent Protection Strategy Through 2044

Benzinga
ONCY
2026.09.29

Oncolytics Biotech Publishes Data On Pelareorep Immunotherapy In Proceedings Of The National Academy Of Sciences

Benzinga
ONCY
2026.09.28

Oncolytics Biotech's All Planned Facilities For Part A Of REO 033 Trial Activated, Multiple Participants Admitted

Seeking Alpha
ONCY
2026.04.25

Oncolytics Could Re-Rate As Pelareorep Focuses On Registrational Paths (NASDAQ:ONCY)

Investing
ONCY
2026.03.02

Oncolytics launches phase 2 colorectal cancer study REO 033

Investing
ONCY
2026.02.24

Oncolytics to wind down GOBLET study, focus on U.S. registration

Investing
ONCY
2026.02.04

Oncolytics Biotech stock soars after FDA grants Fast Track Designation

Investing
ONCY
2026.01.12

Pelareorep-atezolizumab shows promising results in anal cancer

Investing
ONCY
2026.01.09

Oncolytics Biotech plans to shift incorporation from Canada to Nevada

Investing
ONCY
2026.01.08

Oncolytics Biotech files patent application to extend pelareorep protection

Investing
ONCY
2026.01.07

Oncolytics Biotech expands GI cancer advisory board with three experts

Investing
ONCY
2025.12.16

Oncolytics reports 33% response rate in hard-to-treat colorectal cancer

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stocks
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Subscribe to algo trading news
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd